Introduction {#S1}
============

Antimicrobial resistance (AMR) genes originate from environmental bacteria, especially from soil bacteria, which are thought to have evolved together with related antibiotic production organisms over thousands of years ([@B14]; [@B35]). It usually takes several years of clinical use of drugs associated with mobile AMR genes for the genes to penetrate human pathogen populations ([@B28]). Hundreds of mobile AMR genes have been found in *Klebsiella pneumoniae* ([@B25]; [@B33]). The accumulation of AMR in these bacteria is mainly related to horizontal gene transfer assisted by plasmids and mobile gene elements ([@B39]), such as insertions (IS), transposons (Tn), and integrons (In). Evolutionary forces drive the growth of bacteria in many circumstances, and survival under less than optimal conditions is essential. Therefore, bacteria often acquire the ability to survive in the presence of an antimicrobial agent in an effort to adapt to their environment ([@B1]).

Bacteriophages (phages) are viruses that infect bacteria; they constitute a large and diverse group within microorganisms. It is estimated that approximately 20% of the total bacterial genome has been obtained from phage elements, indicating an evolutionary correlation between bacteria and phages ([@B6]). Phages induce antiviral immunity and prevent the elimination of bacterial infections ([@B44]). A number of studies have shown that in mammals, phages are also related to bacterial colonization ([@B13]; [@B42]).

Phages that integrate into bacterial chromosomes are called prophages, which are important gene elements of bacterial chromosomes and enable horizontal gene transfer between bacteria and phages ([@B7]). The interaction between phages and bacteria may have evolutionary benefits because many bacterial species have phage-derived factors in their genomes that benefit their survival, and such genetic exchange can be promoted given the appropriate ecological conditions ([@B8]). For example, [@B46] has described how prophage DNA can help the host survive under multiple adverse conditions including the presence of antibiotics and environmental stress. Prophages also encode the virulence factors of many pathogens ([@B9]; [@B16]). Attempts have been made to use phages to treat multidrug-resistant bacterial infections ([@B22]; [@B45]; [@B15]; [@B27]), but their function and significance remain unclear ([@B26]). Only recently have studies confirmed that phages play more crucial roles than previously expected in the maintenance and dissemination of acquired resistance genes ([@B8]).

*Klebsiella pneumoniae* is an important conditional pathogen in hospitals and the environment. The global multidrug resistance (MDR) problem of *K. pneumoniae* is becoming more and more serious, and the antimicrobial treatment options for infection are limited ([@B40]). The role of prophages in highly virulent and multidrug resistant pathogens, including *K. pneumoniae*, has received much attention ([@B5]). Building on previous studies, herein, four strains of *K. pneumoniae*, 19051, 675920, 721005, and 911021, from hospital patient specimens and 16 genomes of *K. pneumoniae* from GenBank were compared and analyzed for the presence of prophage DNA at the *sap* sites in an effort to confirm its importance as the basis of the horizontal transfer of resistance genes in the prophage DNA. A novel transposon, Tn*6556*, was discovered and the related properties of the prophage genes inserted into the *sap* sites of *K. pneumoniae* are described. This study describes the diversity of prophage genetic mutations, and deciphers the detailed molecular mechanisms of AMR for *K. pneumoniae* harboring prophage DNA.

Materials and Methods {#S2}
=====================

Ethics Statement {#S2.SS1}
----------------

This study was approved by the Ethics Committee of the Taizhou Municipal Hospital, Taizhou University, Zhejiang, China, and written informed consent was obtained from each of the participants in accordance with the Declaration of Helsinki. The rights of the research subjects were protected throughout, and we confirm that this study was conducted in our hospital.

The use of human specimens and all related experimental protocols were approved by the Committee on Human Research of the indicated institutions, and the protocols were carried out in accordance with approved guidelines.

Bacterial Strains and Sequencing of the 16S rRNA Gene {#S2.SS2}
-----------------------------------------------------

*Klebsiella pneumoniae* strains 19051 and 721005 were isolated from urine samples of two patients in hospital in 2011 and 2013. *K. pneumoniae* strain 911021 was obtained from the urine of a patient in a teaching hospital in 2014. *K. pneumoniae* strain 675920 was obtained from a patient's sputum in another hospital in 2015. *Escherichia coli* TOP10 (Invitrogen, Carlsbad, CA, United States) was used as the host for cloning and azide-resistant *E. coli* J53 was used as the recipient strain for the conjugation experiments.

For PCR amplification of the almost complete 16S rRNA genes of the *K. pneumoniae* strains, the following universal eubacterial primers were used: AGAGTTTGATYMTGGCTCAG (forward), and TACCTTGTTACGACTT (Y, T or C; M, A or C) (reverse). The length of the amplicon was about 1,500 bp ([@B21]). The Taq enzyme was a Fermentas Taq:Pfu 3:1 mixture (ThermoFisher Scientific, Burlington, VT, United States). The 30 μl reaction contained 1.5 U of enzyme. Amplification was carried out using a temperature program consisting of initial denaturation at 94°C for 3 min, 30 cycles of denaturation at 94°C for 40 s, annealing at 50°C for 40 s, extension at 72°C for 1 min, and final extension at 72°C for 5 min. The PCR products were bidirectionally sequenced to confirm their identity.

Conjugative Transfer of Prophage DNA {#S2.SS3}
------------------------------------

Sodium azide-resistant *E. coli* J53 was used as a receptor, and the prophage-containing *K. pneumoniae* strains 19051, 675920, 721005, and 911021 were used as donors for the conjugative transfer experiments. Small amounts (10--20 μl) of donor and recipient glycerol bacteria were inoculated in 3 ml of brain heart infusion (BHI) broth (BD Biosciences, San Jose, CA, United States). After culture overnight, the donor bacteria were mixed with the recipient bacteria, centrifuged, resuspended in 80 μl of BHI broth, supplemented with a resuspended bacterial solution at the surface of a filter (filter size 1 cm^2^, pore size 0.45 μm), and the filter was adhered to BHI (BD Biosciences) agar plates. The cells were fully absorbed by the filter and cultured at 37°C for 12--18 h. The bacteria were then washed from the filter and spotted on to the BHI agar plates containing 200 μg/ml sodium azide and 50 μg/ml amikacin to select conjugons harboring the prophage.

Sequencing and Sequence Assembly {#S2.SS4}
--------------------------------

Genomic DNA was isolated from each of the 19051, 721005, and 911021 isolates using a Qiagen Blood & Cell Culture DNA Maxi Kit (Qiagen, Hilden, Germany). Genome sequencing was performed with a sheared DNA library with an average size of 15 kb (ranging from 10 to 20 kb) on a PacBio RSII sequencer (Pacific Biosciences, Menlo Park, CA, United States), as well as a paired-end library with an average insert size of 400 bp (ranging from 150 to 600 kb) on a HiSeq sequencer (Illumina, San Diego, CA, United States). The paired-end short Illumina reads were used to correct the long PacBio reads utilizing proovread ([@B24]), and then the corrected PacBio reads were assembled *de novo* utilizing SMART *de novo*^[1](#footnote1){ref-type="fn"}^.

For the 675920 isolate, genome sequencing was performed with a Qiagen large construct kit with sequencing from a mate-pair library with average insert size of 5,000 bp using a MiSeq sequencer (Illumina, San Diego, CA, United States). Sequence assembly was performed as described previously ([@B20]). Briefly, the contigs were assembled using Newbler 2.6 ([@B34]).

Sequence Annotation and Comparison {#S2.SS5}
----------------------------------

Open reading frames and pseudogenes were predicted using *RAST*2.0 ([@B4]), *BLASTP/BLASTN* ([@B2]), *UniProtKB/Swiss-Prot* ([@B3]), and *RefSeq* databases ([@B37]). Annotation of drug resistance genes, mobile elements, and other features was performed using online databases such as *CARD* ([@B29]), *ResFinder* ([@B48]), *ISfinder* ([@B43]), *INTEGRALL* ([@B31]), and the Tn Number Registry ([@B41]). Multiple and pairwise sequence comparisons were performed using *MUSCLE* 3.8.31 ([@B19]) and *BLASTN*. The genome map was drawn using *Inkscape* 0.48.1^[2](#footnote2){ref-type="fn"}^.

Phenotypic Assays {#S2.SS6}
-----------------

The method used for testing bacterial resistance was BioMérieux VITEK2, and the results were determined in accordance with the 2017 Clinical and Laboratory Standards Association (CLSI) guidelines ([@B11]).

Comparison of the Single Nucleotide Polymorphisms of the Backbone Sequence and Insertion Site of the Variable Region {#S2.SS7}
--------------------------------------------------------------------------------------------------------------------

The evolution tree of the nucleotide sequence for the single nucleotide polymorphisms (SNPs) of the backbone was inferred using the Maximum Likelihood method. The analyses were conducted using MEGA 7.0.14 software. The insertion gene elements of the prophage variable region were identified using MeV4.9.0 software.

Sequence Coverage and Identity of Prophage DNA, and Drug Resistance Genes or Mobile Gene Elements of the Variable Region {#S2.SS8}
------------------------------------------------------------------------------------------------------------------------

The hotmaps of sequence identity and coverage of prophage DNA and the comparative study of the drug resistance genes or mobile gene elements in the variable region were drawn with MeV 4.9.0 software.

Nucleotide Sequence Accession Numbers {#S2.SS9}
-------------------------------------

Nucleotide sequence accession numbers of the prophage DNA sequences in the four strains, namely, 19051, 675920, 721005, and 911021, and the 16 genomes of *K. pneumoniae* from GenBank are shown in [Table 2](#T2){ref-type="table"}.

Results {#S3}
=======

Antimicrobial Susceptibility Tests and Transferrable Features {#S3.SS1}
-------------------------------------------------------------

The 16 S rRNA sequences were determined to be *K. pneumoniae* using BLAST. The results of the antimicrobial susceptibility tests on four isolates of *K. pneumoniae* (19051, 675920, 721005, and 911021) are shown in [Table 1](#T1){ref-type="table"}. After these tests, we used *E. coli* J53 as a recipient strain to conduct conjugative transfer experiments on Φ19051-sap, Φ675920-sap, Φ721005-sap, and Φ911021-sap of *K. pneumoniae* harboring prophage. However, we could not create conjugons carrying prophage despite repeated trials.

###### 

Antimicrobial drug susceptibility profiles.

  **Category**       **Antimicrobial drug**          **MIC (mg/L)/antimicrobial susceptibility**           
  ------------------ ------------------------------- --------------------------------------------- --- --- ---
  Penicillins        Ampicillin                      R                                             R   R   R
                     Ampicillin/sulbactam            R                                             R   R   R
                     Piperacillin                    R                                             R   R   R
                     Piperacillin/tazobactam         R                                             R   R   R
  Cephalosporins     Cefazolin                       R                                             R   R   R
                     Cefuroxime                      R                                             R   R   R
                     Cefuroxime axetil               R                                             R   R   R
                     Ceftazidime                     R                                             R   R   R
                     Ceftriaxone                     R                                             R   R   R
                     Cefepime                        R                                             R   R   R
  Monobactam         Aztreonam                       R                                             R   R   R
  Carbapenems        Imipenem                        R                                             R   R   R
                     Meropenem                       R                                             R   R   R
  Aminoglycosides    Amikacin                        R                                             R   S   R
                     Gentamicin                      R                                             R   I   R
                     Tobramycin                      R                                             R   R   R
  Fluoroquinolones   Ciprofloxacin                   R                                             R   R   R
                     Levofloxacin                    R                                             R   R   R
  Furan              Nitrofurantoin                  R                                             R   I   R
  Sulfanilamides     Trimethoprim/Sulfamethoxazole   R                                             R   R   R

S = sensitive; R = resistant; I = intermediately resistant.

Comparison and Analysis of Prophage DNA {#S3.SS2}
---------------------------------------

The 20 prophages in this study were all identified from the *K. pneumoniae* chromosomes. A naming convention of ΦXXX-sap was used to indicate where the prophage sequences were inserted into the *sap* sites of the chromosomes. The shortest prophage sequence was 18 kb and the longest was 65 kb, including 39--109 bp open reading frames. The average G + C content in the prophages was 49.6--53.6% ([Figure 1](#F1){ref-type="fig"}, [Table 2](#T2){ref-type="table"}, and [Supplementary Table S1](#SM1){ref-type="supplementary-material"}). The region from 1 to 1,633 bp at the 5′ end was the common core backbone region of all sequences. All sequences contained the core genes *int* and *umuCD* except for ΦGOS436-sap and ΦGOS442-sap ([Figure 1](#F1){ref-type="fig"}). The same 16 bp in the forward direction sequences (DRs: target site duplication signals) was confirmed at both sides of all sequences ([Figure 1](#F1){ref-type="fig"}). A more detailed genomic comparison revealed that the same or different sites in the backbones of the prophages were interrupted by various insertion sequences, including IS*1R*, IS*1T*, IS*2*, IS*26*, IS*Kpn26*, IS*Kpn28*, Tn*6556*, MDR, and the In27-related region, except for in ΦGoe154414-sap, ΦKPNIH50-sap, and ΦKPNIH39-sap ([Table 2](#T2){ref-type="table"}). Compared with Φ34618-sap, the sequences of the backbone regions of the other prophages were gradually lost. Only *int* and *umuCD* were highly conserved core genes ([Figure 1](#F1){ref-type="fig"}).

![Comparison of linear analysis of the prophage DNA sequences. The linear analysis of the prophage DNA sequences for Φ19051-sap, Φ675920-sap, Φ721005-sap, and Φ911021-sap compared with 16 GenBank prophage DNA sequences (GenBank accession numbers are shown in [Table 2](#T2){ref-type="table"}). Genes are indicated by arrows; characteristics of function and classification are marked with colors for genes and mobile gene elements. Shaded parts indicate homologous regions (nucleotide homology \>95%).](fmicb-10-02840-g001){#F1}

###### 

Major features of prophages analyzed.

  **Prophage**     **Category**                                                   
  ---------------- ---------------------- -------- ----- ------ ----------------- ------------------------------------
  Φ34618-sap       [CP010392](CP010392)   65,478   109   51.9   *K. pneumoniae*   IS*Kpn28*, IS*Kpn26*, Tn*6556*^\#^
  Φ20046-sap       [CP028783](CP028783)   59,286   94    51.5   *K. pneumoniae*   IS*Kpn28*, Tn*6556*\#
  ΦGOS436-sap      [CP023907](CP023907)   50,549   76    51.2   *K.pneumoniae*    IS*Kpn28*, IS26, IS26
  Φ3562-sap        [CP025005](CP025005)   47,619   72    51.0   *K.pneumoniae*    IS*Kpn28*, IS*Kpn26*, IS26
  ΦCAV1392-sap     [CP011578](CP011578)   42,258   62    50.9   *K. pneumoniae*   IS26
  ΦGeo154414-sap   [CP018337](CP018337)   57,375   73    51.6   *K. pneumoniae*   --
  ΦAR0152-sap      [CP021944](CP021944)   57,211   73    51.6   *K. pneumoniae*   IS*1T*
  ΦKP5-sap         [CP012426](CP012426)   56,637   79    51.4   *K. pneumoniae*   IS*2*, IS*1T*
  ΦKPNIH50-sap     [CP026177](CP026177)   55,270   69    51.9   *K. pneumoniae*   --
  Φ459-sap         [CP018306](CP018306)   51,879   70    51.3   *K. pneumoniae*   IS*1T*
  ΦKPNIH39-sap     [CP014762](CP014762)   52,648   63    50.1   *K. pneumoniae*   --
  Φ911021-sap      [CP022882](CP022882)   28,584   53    51.1   *K. pneumoniae*   ΔTn*6556*\#
  Φ675920-sap      [CP033242](CP033242)   29,785   57    51.2   *K. pneumoniae*   IS*Kpn26*, ΔTn*6556*\#
  Φ20079-sap       [CP029384](CP029384)   29,685   59    51.0   *K. pneumoniae*   IS*Kpn28*, ΔTn*6556*\#
  ΦKPNIH36-sap     [CP014647](CP014647)   30,388   54    52.7   *K. pneumoniae*   IS*Kpn26*, Tn*6556*\#
  Φ721005-sap      [CP022997](CP022997)   51,335   87    49.6   *K. pneumoniae*   MDR region\#
  ΦGOS442-sap      [CP023925](CP023925)   35,881   65    50.5   *K. pneumoniae*   IS*2*, IS*1T*, IS*Kpn28*, IS*1R*
  ΦBAA2146-sap     [CP006659](CP006659)   23,317   46    51.9   *K. pneumoniae*   ΔTn*6556*\#
  ΦINF164-sap      [CP006659](CP006659)   18,377   46    53.6   *K. pneumoniae*   Tn*6556*\#
  Φ19051-sap       [CP024556](CP024556)   28,884   39    52.1   *K. pneumoniae*   In27-related region\#

\#

Accessory modules containing resistance genes. Detailed data are listed in

Supplementary Material

.

Massive Genetic Acquisitions or Losses Resulting in Evolution of Prophage DNA {#S3.SS3}
-----------------------------------------------------------------------------

At least nine large genetic structures that appeared to be from acquisitions or losses were identified in the 20 prophages in this study ([Figure 2](#F2){ref-type="fig"}). First, IS*2* was inserted into the genes *int* (integrase gene) (ΦKP5-sap) and *recT* (recombinant repairing protein RecT) (ΦGOS442-sap), leading to both genes being disrupted into two parts, Δ*int-5*′ and Δ*int-3*′, and Δ*recT-5*′ and Δ*recT-3*′, but no base loss was induced. Second, the insertion of IS*1T* into the *orf309* and *orf396* genes was generally determined; however, these simple insertions might not delete bases in ΦAR0152-sap, ΦKP5-sap, Φ459-sap, and ΦGOS442-sap. Third, IS*Kpn28* was inserted upstream of the *hol* (*holin*) gene, resulting in a 3.1-kb loss in Φ20046-sap, but no base variation occurred in Φ34618-sap, ΦGOS436-sap, Φ3562-sap, Φ20079-sap, and ΦGOS442-sap. Fourth, the insertion of IS*1R* downstream of the *yjdB* gene resulted in a 52.2-kb loss in ΦGOS442-sap. Fifth, the insertion of IS*Kpn26* upstream of the *orf336* gene caused a 10.3-kb loss in Φ3562-sap and a 32.3-kb loss in ΦKPNIH36-sap. Sixth, insertion of Tn*6556* upstream of the *hin* gene resulted in a 35.2-kb loss in each of Φ911021-sap, Φ675920-sap, and Φ20079-sap, a 37.6-kb loss in ΦBAA2146-sap, and a 45.2-kb loss in ΦINF164-sap; however, the insertion of Tn*6556* upstream of the *hin* gene in Φ34618-sap, Φ20046-sap, and ΦKPNIH36-sap did not cause any sequence deletion. Seventh, two IS*26*s were inserted into ΦGOS436-sap, located in the middle and downstream of the *orf3069* gene, splitting this gene into two parts, Δ*orf3069-5*′ and Δ*orf3069-3*′, resulting in an 8.9-kb deletion in ΦGOS436-sap. IS*26* in ΦCAV1392-sap inserted upstream of the *hin* gene resulted in a 13.4-kb loss, while the insertion of IS*26* upstream of the *hin* gene in Φ3562-sap also did not cause any base loss. Eighth, among the 20 sequences analyzed, only Φ721005-sap containing the MDR region, located upstream of the *retA* gene (reverse transcriptase gene), resulted in a 34.1-kb loss, including *hin* and its upstream genes. Ninth, the exogenous insertion into Φ19051-sap of the In27-related region, located between the *hin* and *exoVIII* genes (deoxyribonuclease *exoVIII*), resulted in a 45-kb loss, involving part of the *hin* and *exoVIII* genes.

![Diagram of the insertion site for accessory modules (variable regions). The genes are indicated by arrows; the shaded parts indicate homologous regions (nucleotide homology \>95%). Numbers 1 to 5 represent the hotspots with insertions of variable regions, the red arrow and the mark directly above it indicate the specific position and element of the insertion, and the oblique upward arrow marked on the right side of the part of the red arrow indicates the base of the backbone in the prophage caused by the insertion of the variable region, resulting in deletions of the base (accurate to 0.1 kb).](fmicb-10-02840-g002){#F2}

The MDR Region From Φ721005-Sap {#S3.SS4}
-------------------------------

The largest number of drug resistance genes in Φ721005-sap was found to be located in the MDR region ([Figure 3](#F3){ref-type="fig"}), followed by the Tn*1548*-related region, in which In27 in the original Tn*1548* was replaced by In127, the truncated *repAciN* gene, and a 7.2-kb-long unknown functional region *trb*-to-*pem*, a 2.5-kb-long Tn*2* remnant (including Tn*2* IRL and truncated *tnpA*), and complete Tn*6502* (containing the beta-lactamase resistance gene *bla*~*CTX--M--*55~). Tn*1548* was shown to be a composite transposon flanked by IS*26* with no forward direction repeats (DRs) at both ends and its structure was IS*26*-In27-IS*CR1*-ΔIS*Ec28*-*armA* (aminoglycoside resistance gene)-IS*Ec29*-*msr(E)*- *mph(E)* (macrolide resistance gene)-*orf543*-*repAciN*-IS*26*. In27 in Tn*1548* could be replaced by different class 1 integrons, forming many Tn*1548*-related elements ([@B23]; [@B18]). In127, unlike In27, had only one *aadA2* (aminoglycoside resistance gene) gene cassette ([Figure 3](#F3){ref-type="fig"}).

![Comparison of an exogenous insertion containing a drug resistance gene and the relevant gene elements. Genes are indicated by arrows; genes, mobile elements, and other features are colored based on function and classification. Shaded regions indicate homologous nucleotides (nucleotide homology \>95%); the numbers in parentheses indicate the relative nucleotide site. The exogenous insertion (Tn*6556*) with the identified sequence is included in the Figure at the lower left part.](fmicb-10-02840-g003){#F3}

Evolution of the In27-Related Region From Φ19051-Sap {#S3.SS5}
----------------------------------------------------

Tn*1696* belongs to the Tn*21* subgroup of the Tn*3* transposon family. It was produced by insertion of the dissociation site (*res*) into the core backbone region by class I integron In4, and its structure was shown to be IRL (left reverse repeat)-*tnpA* (transposase)-*tnpR* (dissociation enzyme)-*res* (dissociation site)-*mer* (mercury resistance site)-IRR (right reverse repeat sequence) ([@B38]). The In27-related region in Φ19051-sap was derived from Tn*1696*, which was produced by five major evolutionary events in Tn*1696* as follows. First, the truncated IS*5075* was inserted into the middle of the IRR, resulting in only a 22-bp remnant in the IRR. Second, the incomplete In27 was inserted into the same *res* site of In4, and the *res* was truncated to the 5′ end as a 75-bp remnant. The sequences of the In27 and In4 gene cassettes were completely different; the In27 gene cassette featured *aadA2*-*gcuF*-*dfrA12*, while the In4 gene cassette contained *cmlA1*-*aadA2*-*orfE*-*aacC1*. Moreover, the 3′-CS of In27 was absent. *AadA2* and *dfrA1* are genes conferring aminoglycoside resistance and trimethoprim resistance, respectively, and *gcuF* encodes a pseudo protein. The other three events included the insertion of Δ*ble* (bleomycin resistance gene) and *nimA* (unknown function), the deletion of the *mer* gene, and the replacement of IS*26* and ΔIS*5075* by IS*6100*. Downstream of IS*5075* was ΔGI*sul2* (3′ end of GI*sul2*: *resG*-*orf225*-IS*CR2*-*glmM*-*sul2*) and IS*26*. GI*sul2* is a large mobile element carrying integrase (*int*), including the resolvase gene *resG*, several conjugative transfer genes, sulfonamide resistance gene *sul2*, and IS*CR2* sequences, and is present in various bacteria ([@B36]).

The Novel Composite Transposon Tn*6556* {#S3.SS6}
---------------------------------------

Tn*6556* is a novel composite transposon first discovered in Φ34618-sap, ΦKPNIH36-sap, and Φ20046-sap ([Figure 3](#F3){ref-type="fig"}). Tn*6556* consists of class I integron In127 and three independent inserts, IS*26*-In127 (Δ*intl1*-*aadA2*-*qacED1*-*sul1*-*orf5*-*orf6*)- IS*6100*-IS*26*, and 8-bp forward DRs on both ends. Further truncation of the Δ*intl1* gene made Tn*6556* incomplete in ΦBAA2146-sap. The deletion of IS*6100* and its upstream *orf6* and *orf5*, together with the truncation of *sul1*, resulted in significant truncation of Tn*6556* in Φ675920-sap, Φ911021-sap, and Φ20079-sap, but the *aadA2* gene remained intact. No forward DRs were found on both ends of Tn*6556* in ΦINF164-sap, ΦBAA2146-sap, Φ675920-sap, Φ911021-sap, and Φ20079-sap. The classical structure of the prototype for the Tn*402*-associated class I integron is IRi (integron end inverted direction repeat) -5′-CS \[5′-conserved fragment: *intI1* (integrase), *attI1* (specific recombination site), GC (gene cassette) array\], 3′-CS \[3′-conserved fragment: *qacED1*-*sul1*-*orf5*-*orf6*\], a Tn*402tni* module \[*tniA* (transposase) -*tniB* (ATP-binding protein) -*tniQ* (transposition auxiliary protein) -*res*-*tniR* (serine dissociation enzyme)\], and IRt (*tni* terminal inverted direction repeat). In127 contained a truncated 5′-CS, a gene cassette, and a complete 3′-CS, but did not involve a Tn*402tni* module. The transposases of IS*26* and IS*6100* on both sides of Tn*6556* might mediate transposon mobility ([@B41]).

Evolutionary Analysis of the Prophage DNA Sequences {#S3.SS7}
---------------------------------------------------

The evolutionary relationships of the 20 prophage DNAs are shown in [Figures 4A--C](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}. The identities of the related SNPs found in the backbone sequence were obtained with high confidence among the ΦBAA2146-sap, ΦINF164-sap, Φ721005-sap, Φ675920-sap, Φ911021-sap, Φ20079-sap, ΦCAV1392-sap, Φ3562-sap, ΦGOS436-sap, Φ20046-sap, and Φ34618-sap ([Figure 4A](#F4){ref-type="fig"}, all identified above a 93% confidence level, purple line), and the ΦKP5-sap ([Figure 4A](#F4){ref-type="fig"}, identified at a 96% confidence level, purple line). The identities of the related SNPs found in ΦAR0152-sap and ΦGOS442-sap were obtained at a 99% confidence level ([Figure 4A](#F4){ref-type="fig"}, purple line). These results suggested that this region of the backbone sequence was largely homologous. However, regions of the backbone sequence where the identities of the SNPs were associated with a confidence level of less than 60% indicated that the nucleotide sequence of that backbone region was diverse compared with the above region. These results are consistent with the elements and sites of insertion shown in [Figures 4B,C](#F4){ref-type="fig"}. [Figure 4B](#F4){ref-type="fig"} shows the insertion sites of the genes or gene elements. [Figure 4C](#F4){ref-type="fig"} graphically shows the inserted genes or gene elements. Taken together, [Figure 4](#F4){ref-type="fig"} summarizes the evolution and changes of the 20 prophage DNAs, including the sites and types of inserted genes or gene elements, suggesting there are contradictory features in phage DNA stability and variation.

![Evolutionary relationships of prophage DNA for four strains of *K. pneumoniae* DNA and 16 prophage DNAs identified from GenBank. **(A)** Evolution tree of prophage backbone. The evolutionary history was inferred using the Maximum Likelihood method. **(B)** Insertion site of the variable region. Insertion sites ➀, ➁,➂, ➃, and ➄ are identical to those of [Figure 2](#F2){ref-type="fig"}. **(C)** Gene elements of the prophage variable region. Data is also collected from [Figure 2](#F2){ref-type="fig"}.](fmicb-10-02840-g004){#F4}

![Sequence coverage and identity among the prophage DNAs for four strains of *K. pneumoniae* and 16 prophage DNAs identified from GenBank. There is high sequence identity (average nucleotide homology \>95%), but various coverage among the 20 prophage DNAs based on [Supplementary Table S1](#SM1){ref-type="supplementary-material"}.](fmicb-10-02840-g005){#F5}

![The correlativity of drug resistance genes or mobile gene elements are determined with *CARD*, *ResFinde*r, and Tn Number Registry databases among the four strains of *K. pneumoniae* and 16 prophage DNAs identified from GenBank. There are only 10 prophage DNAs harboring drug resistance genes, which are generally located on mobile gene elements such as the MDR region, In27-related region and novel Tn*6556*.](fmicb-10-02840-g006){#F6}

[Figure 5](#F5){ref-type="fig"} illustrates the high identity of the partial sequence in the 20 prophage DNAs, indicating an average nucleotide identity (homology) of \>95%, consistent with the shaded regions in [Figures 1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}. However, the various coverages of the 20 prophage DNAs vividly suggest the polymorphism of evolution and change. [Figure 6](#F6){ref-type="fig"} reveals the relationship among the drug resistance genes or gene elements in the variable region, suggesting the ever-changing characteristics of gene elements. These results suggest the high sequence identification and homology of prophage DNA and helped to characterize the evolutionary diversity of the prophage DNA examined in this study.

Discussion {#S4}
==========

The analysis of four prophage DNA sequences and 16 similar prophage DNA sequences from GenBank indicated that they were all specifically inserted into the *sap* sites of *K. pneumoniae* chromosomes. It is well known that *sapABC* is a permease of the peptide transport system, which mediates the transport of phages or particles into *K. pneumoniae* cells; accordingly, the capsule biosynthesis of phage in *K. pneumoniae* is productive and regulated ([@B17]). The *sap ABC* transporter promotes capsule production by increasing gene expression in the middle of the capsule ([@B17]). Then, the *sapABC* system replicates and inserts phage DNA into the *K. pneumoniae* DNA, forming prophage DNA. Over time, after experiencing the above-mentioned massive genetic acquisitions and losses, including changes to the lysogenic transformation regions, DNA replication regions, and transcriptional regulatory regions of the prophage, among others, the bases of the backbone regions were gradually lost over the course of evolution. This would increase excessive insertions with or without drug resistance genes or gene elements such as IS*1T*, IS*1R*, IS*26*, IS*Kpn26*, IS*Kpn28*, Tn*6556*, In27-related, and the MDR region. These factors enable the host bacteria to reduce their metabolism and external pressures, promoting better adaptation to the environment, and revealing the evolutionary benefits of prophage DNAs.

Over the course of prophage evolution, the *int* gene has always been present, suggesting that it is the most conserved core of the backbone region. Owing to the evolutionary selective pressures present during the process of integrating DNA into host bacteria, the prophage DNA inevitably undergoes gene mutations and deletions. Transfer of prophage DNA requires two reactions: first, excision of the prophage DNA from the host bacterium and second, integration of the prophage into a new host bacterium. The excision of the prophage involves a functional *xis* gene, but this is not absolute. If there is no Xis enzyme, the integration enzyme (Int) and the integral host factor (IHF) can complete the transfer of the prophage DNA. Integrating a prophage into a new host requires a functional integrase (Int) followed by a specific binding site (*attB*) in the host, and any nucleotide changes in the core region of the binding site might result in failure of the prophage cell integration ([@B32]). Likewise, if the conjugate was integrated into a bacterial cell, the phage could express a protein that was toxic to the cell and kill all exconjugants. Therefore, the failure of the conjugate transfer experiment in this study is not surprising. It is generally accepted that DNA excision depends on phage-encoded proteins, and the excision enzyme (Xis) and integrase (Int) are considered to be involved in the first step in prophage induction, allowing the prophage DNA to be excised and then replicated ([@B12]). However, it has also been reported that several prophages of *Staphylococcus aureus* were found to have significantly delayed transcription of the *xis* gene compared with that of the genes encoding the proteins required for DNA replication and prophage-particle production. The result of this delay was the replication of prophage DNA *in situ* within the bacterial genome and subsequent encapsulation of the prophage DNA, which was still attached to the adjacent bacterial DNA ([@B10]; [@B12]).

Based on the genes or genetic mobile elements investigated, some of prophages appeared functional and were even phenotypically expressed. Comparative analysis of the 20 prophage genomes from the *sap* site of the *K. pneumoniae* chromosome indicated that a positive repeat of 16 bp in length was observed at both ends of all prophages, and the sequences were identical, labeled as *attL* and *attR* ([Figure 1](#F1){ref-type="fig"}, a small square flag at both ends of the sequence). Compared with the reference sequence Φ34618-sap, the sequence of the backbone regions of the other prophages was gradually lost. However, the most stable core genes were *int* and *umuCD* ([Figure 1](#F1){ref-type="fig"}). At least nine exogenous insertion regions including IS*1R*, IS*1T*, IS*2*, IS*26*, IS*Kpn26*, IS*Kpn28*, Tn*6556*, MDR, and In27-related regions were determinate in this study ([Table 1](#T1){ref-type="table"}), in which Tn*6556*, MDR, and the In27-related regions were involved as resistance genes. Additionally, a novel composite transposon Tn*6556* was discovered in the *K. pneumoniae* chromosome. Different insertion elements of a series of exogenous insertion regions including IS and Tn on the prophage had relatively specific insertion sites where IS*Kpn28* was located upstream of the *hol* gene, IS*Kpn26* was located upstream of the *orf* gene, and Tn*6556* was located upstream of the *hin* gene. As the simplest transposition element, the shearing and transfer of IS was accomplished by its own transposase. Tn*6556* was flanked by two repeating IS*26s*, and this repetitive IS mediated homologous recombination of Tn*6556*, and also resulted in genetic loses near the recombination site resulting in diversity in the prophage DNA.

Tn*6556* containing In127 was discovered for the first time in this study ([Tables 2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [Figures 2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}, [6](#F6){ref-type="fig"}). The results of the antimicrobial susceptibility test shown in [Table 1](#T1){ref-type="table"} indicated that the *K. pneumoniae* strains were highly resistant to various antimicrobial agents, suggesting that in addition to the phenotypic expression of the resistance genes or gene elements carried on the chromosome, one or more plasmids carrying resistance genes or gene elements might also be involved ([Tables 1](#T1){ref-type="table"}--[3](#T3){ref-type="table"} and [Figures 1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}, [6](#F6){ref-type="fig"}), and warrants further study. The results of [Figure 2](#F2){ref-type="fig"} summarizing the five sites of base insertion and nine types of base acquisition or loss in prophage DNA ([Table 2](#T2){ref-type="table"} and [Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4B,C](#F4){ref-type="fig"}) show in detail the molecular mechanism behind the evolution of the prophage DNA and the changes of AMR ([Table 3](#T3){ref-type="table"} and [Figure 6](#F6){ref-type="fig"}). AMR encoded in a bacterial chromosome might originate from new mutations or acquired AMR genes, which could be maintained by replication without selection pressure ([@B33]). This process would facilitate the evolutionary adaptation of bacteria and has a potential impact on the monitoring and treatment of bacterial infections ([@B42]). Our results confirm that AMR genes are encoded in the chromosome of *K. pneumoniae* ([@B30]), and they can be classified as "core AMR gene" or "acquired AMR gene" ([@B47]). Furthermore, these results indicate that the incorporation of phage DNA has resulted in a diverse set of *K. pneumoniae* chromosomes, confirming their ever-changing roles in the evolutionary success of the bacterium. This study did not examine how the phages of the relevant gene locus are induced and transferred to other strains, and how these phages play a role in the transfer of AMR genes, and therefore these questions require further investigation in future studies.

###### 

Drug resistance genes in mobile elements analyzed in this study.

  **Prophage**   **Resistance marker**   **Resistance phenotype**                 **Nucleotide position**   **Region located**
  -------------- ----------------------- ---------------------------------------- ------------------------- ---------------------
  Φ34618-sap     *aadA2*                 Aminoglycoside resistance                51522..52301              Tn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   52465..52812              
                 *sul1*                  Sulfonamide resistance                   52806..53645              
  Φ20046-sap     *aadA2*                 Aminoglycoside resistance                47240..48019              Tn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   48183..48530              
                 *sul1*                  Sulfonamide resistance                   48524..49363              
  Φ911021-sap    *aadA2*                 Aminoglycoside resistance                18831..19610              ΔTn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   19774..20121              
                 Δ*sul1*                 Sulfonamide resistance                   20115..20673              
  Φ675920-sap    *aadA2*                 Aminoglycoside resistance                20032..20811              ΔTn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   20975..21322              
                 Δ*sul1*                 Sulfonamide resistance                   21316..21874              
  Φ20079-sap     *aadA2*                 Aminoglycoside resistance                19932..20711              ΔTn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   20875..21222              
                 Δ*sul1*                 Sulfonamide resistance                   21216..21774              
  ΦKPNIH36-sap   *aadA2*                 Aminoglycoside resistance                18342..19121              Tn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   19285..19632              
                 *sul1*                  Sulfonamide resistance                   19626..20465              
  Φ721005-sap    *aadA2*                 Aminoglycoside resistance                18830..19609              MDR region
                 *qacED1*                Quaternary ammoniumcompound resistance   19773..20120              
                 *sul1*                  Sulfonamide resistance                   20114..20953              
                 *armA*                  Aminoglycoside resistance                24295..25068              
                 *msr(E)*                Macrolide resistance                     27367..28842              
                 *mph(E)*                Macrolide resistance                     28898..29782              
                 *bla*~*CTX--M--*55~     β-lactam resistance                      44246..45121              
  ΦBAA2146-sap   *aadA2*                 Aminoglycoside resistance                11271..12050              ΔTn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   12214..12561              
                 *sul1*                  Sulfonamide resistance                   12555..13394              
  ΦINF164-sap    *aadA2*                 Aminoglycoside resistance                4421..5200                Tn*6556*
                 *qacED1*                Quaternary ammoniumcompound resistance   5364..5711                
                 *sul1*                  Sulfonamide resistance                   5705..6544                
  Φ19051-sap     Δ*ble*                  Bleomycin resistance                     12881..13272              In27-related region
                 *aadA2*                 Aminoglycoside resistance                14469..15248              
                 *dfrA12*                Trimethoprim resistance                  15668..16165              

Detailed data are listed in

Supplementary Material

.

Conclusion {#S5}
==========

The emerging diversity of prophages is the result of base acquisition or loss with a large number of variable regions being associated with insertions of different prophage DNA. This has resulted in various degrees of base loss in the backbone region near the insertion sites, conferring evolutionary diversity on prophage DNA.
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